Impact of subclinical hypothyroidism and thyroid autoimmunity on clinical pregnancy rate after intrauterine insemination in euthyroid women

8Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

Abstract

Objective: This study aimed to evaluate the association between subclinical hypothyroidism and thyroid autoantibodies with clinical pregnancy rate after intrauterine insemination (IUI) in euthyroid women. Methods: In this prospective cohort study, we recruited 497 women who underwent IUI treatment. We assessed thyroid function tests, thyroid antibodies and clinical pregnancy rates of the patients. Results: The patients were divided into two groups according to TSH values: Normal group, n=387, and subclinical hypothyroidism group 2, n=110. The clinical pregnancy rate was 15.2% in the Control Group and 17.3% in the study group (p=0.656). In the Study Group, 35% of the patients had anti-TPO positivity (p=0.531) and 42.1% of the patients had anti-TG positivity (p=0.285). There was no statistically significant difference in clinical pregnancy rates between the groups in terms of antithyroid antibody positivity (p=0.54; p=0.559, respectively). Conclusion: Anti-TPO antibodies and subclinical hypothyroidism had no impact on clinical pregnancy rates in the women submitted to IUI.

Cite

CITATION STYLE

APA

Pekcan, M. K., Ozgu-Erdinc, A. S., & Yilmaz, N. (2019). Impact of subclinical hypothyroidism and thyroid autoimmunity on clinical pregnancy rate after intrauterine insemination in euthyroid women. Jornal Brasileiro de Reproducao Assistida, 23(2), 137–142. https://doi.org/10.5935/1518-0557.20190027

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free